Literature DB >> 23059772

A systematic search for reports of site monitoring technique comparisons in clinical trials.

Julie Bakobaki1, Nicola Joffe, Sarah Burdett, Jayne Tierney, Sarah Meredith, Sally Stenning.   

Abstract

BACKGROUND: As part of a broader methodological programme of work around clinical trial monitoring, we wanted to evaluate the existing evidence for the effectiveness of different monitoring techniques.
PURPOSE: To identify and evaluate prospective studies of the effectiveness of different monitoring strategies.
METHODS: A systematic search of MEDLINE from 1950 onwards, using free-text terms to identify relevant published studies. We intended to extract data on details of comparative techniques, monitoring findings identified by different techniques, and recommendations or identification of areas in need of further research made by authors.
RESULTS: A total of 1222 published abstracts were identified and reviewed. Of these, nine articles described methods for quality control (QC) of clinical trial activities, and one article was identified that compared the same monitoring technique at two timepoints. None included a direct comparison of different monitoring techniques and findings. LIMITATIONS: The search strategy was limited to MEDLINE. However, MEDLINE includes all the journals that tend to report trial methodological research.
CONCLUSIONS: There is a lack of published empirical data that compare monitoring strategies prospectively. Assessment of the usefulness and cost-effectiveness of monitoring techniques in a variety of clinical trial settings and indications is needed.

Mesh:

Year:  2012        PMID: 23059772     DOI: 10.1177/1740774512458993

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  10 in total

Review 1.  The impact of clinical trial monitoring approaches on data integrity and cost--a review of current literature.

Authors:  Rasmus Olsen; Asger Reinstrup Bihlet; Faidra Kalakou; Jeppe Ragnar Andersen
Journal:  Eur J Clin Pharmacol       Date:  2016-01-04       Impact factor: 2.953

2.  INVESTIGATING THE EFFICACY OF CLINICAL TRIAL MONITORING STRATEGIES: Design and Implementation of the Cluster Randomized START Monitoring Substudy.

Authors:  Katherine Huppler Hullsiek; Jonathan M Kagan; Nicole Engen; Jesper Grarup; Fleur Hudson; Eileen T Denning; Catherine Carey; David Courtney-Rodgers; Elizabeth B Finley; Per O Jansson; Mary T Pearson; Dwight E Peavy; Waldo H Belloso
Journal:  Ther Innov Regul Sci       Date:  2015-03-01       Impact factor: 1.778

3.  A randomized evaluation of on-site monitoring nested in a multinational randomized trial.

Authors:  Nicole Wyman Engen; Kathy Huppler Hullsiek; Waldo H Belloso; Elizabeth Finley; Fleur Hudson; Eileen Denning; Catherine Carey; Mary Pearson; Jonathan Kagan
Journal:  Clin Trials       Date:  2019-10-24       Impact factor: 2.486

4.  Impact of a targeted monitoring on data-quality and data-management workload of randomized controlled trials: A prospective comparative study.

Authors:  Claire Fougerou-Leurent; Bruno Laviolle; Christelle Tual; Valérie Visseiche; Aurélie Veislinger; Hélène Danjou; Amélie Martin; Valérie Turmel; Alain Renault; Eric Bellissant
Journal:  Br J Clin Pharmacol       Date:  2019-12-14       Impact factor: 4.335

5.  Increasing value and reducing waste in biomedical research regulation and management.

Authors:  Rustam Al-Shahi Salman; Elaine Beller; Jonathan Kagan; Elina Hemminki; Robert S Phillips; Julian Savulescu; Malcolm Macleod; Janet Wisely; Iain Chalmers
Journal:  Lancet       Date:  2014-01-08       Impact factor: 79.321

6.  Risk-adapted monitoring is not inferior to extensive on-site monitoring: Results of the ADAMON cluster-randomised study.

Authors:  Oana Brosteanu; Gabriele Schwarz; Peggy Houben; Ursula Paulus; Anke Strenge-Hesse; Ulrike Zettelmeyer; Anja Schneider; Dirk Hasenclever
Journal:  Clin Trials       Date:  2017-08-08       Impact factor: 2.486

7.  Comparative costs and activity from a sample of UK clinical trials units.

Authors:  Daniel Hind; Barnaby C Reeves; Sarah Bathers; Christopher Bray; Andrea Corkhill; Christopher Hayward; Lynda Harper; Vicky Napp; John Norrie; Chris Speed; Liz Tremain; Nicola Keat; Mike Bradburn
Journal:  Trials       Date:  2017-05-02       Impact factor: 2.279

8.  Generating evidence on a risk-based monitoring approach in the academic setting - lessons learned.

Authors:  Belinda von Niederhäusern; Annette Orleth; Sabine Schädelin; Nawal Rawi; Martin Velkopolszky; Claudia Becherer; Pascal Benkert; Priya Satalkar; Matthias Briel; Christiane Pauli-Magnus
Journal:  BMC Med Res Methodol       Date:  2017-02-14       Impact factor: 4.615

9.  Assessing the potential for prevention or earlier detection of on-site monitoring findings from randomised controlled trials: Further analyses of findings from the prospective TEMPER triggered monitoring study.

Authors:  William J Cragg; Caroline Hurley; Victoria Yorke-Edwards; Sally P Stenning
Journal:  Clin Trials       Date:  2020-11-24       Impact factor: 2.486

Review 10.  Dynamic methods for ongoing assessment of site-level risk in risk-based monitoring of clinical trials: A scoping review.

Authors:  William J Cragg; Caroline Hurley; Victoria Yorke-Edwards; Sally P Stenning
Journal:  Clin Trials       Date:  2021-02-20       Impact factor: 2.486

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.